Apogee Therapeutics (APGE) Selling, General & Administrative (2022 - 2026)
Apogee Therapeutics (APGE) reported Selling, General & Administrative of $24.34 million for Q2 2026, up 39.4% from $17.46 million a year earlier and up 10.9% from the prior quarter.
Powered by 
Analysis
Apogee Therapeutics (APGE) Selling, General & Administrative (2022 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Apogee Therapeutics' Selling, General & Administrative came in at $83.01 million, up 32.2% year-over-year; for FY2025, it was $70.88 million, up 44.6% from FY2024.
- Selling, General & Administrative has increased for three consecutive years, with a three-year compound annual growth rate of 188.9% (FY2022 to FY2025).
- By year, Selling, General & Administrative came in at $49.01 million in FY2024 (+99.4%), $24.58 million in FY2023 (+735.7%) and $2.94 million in FY2022.
- The Q2 2026 figure ranks as the highest quarterly Selling, General & Administrative in data going back to Q2 2022.
- Year over year, Selling, General & Administrative has now increased in each of the last 11 quarters, with growth averaging 54.3% over the last eight quarters.
- The year-over-year growth in Selling, General & Administrative has ranged between 25.3% (Q4 2025) and 333.7% (Q4 2023) over the last five years.
- Per Business Quant data, the three quarters before Q2 2026 came in at $21.95 million (Q1 2026), $19.61 million (Q4 2025) and $17.1 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Apogee Therapeutics | 10.18 Bn | 7.68 Bn | - | 24.34 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 24.34 Mn |
| Mar 31, 2026 | 21.95 Mn |
| Dec 31, 2025 | 19.61 Mn |
| Sep 30, 2025 | 17.10 Mn |
| Jun 30, 2025 | 17.46 Mn |
| Mar 31, 2025 | 16.71 Mn |
| Dec 31, 2024 | 15.65 Mn |
| Sep 30, 2024 | 12.97 Mn |
| Jun 30, 2024 | 10.92 Mn |
| Mar 31, 2024 | 9.47 Mn |
| Dec 31, 2023 | 8.20 Mn |
| Sep 30, 2023 | 7.24 Mn |
| Jun 30, 2023 | 4.94 Mn |
| Mar 31, 2023 | 4.20 Mn |
| Dec 31, 2022 | 1.89 Mn |
| Sep 30, 2022 | 622,000.00 |
| Jun 30, 2022 | 368,000.00 |
API Access
Apogee Therapeutics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=APGE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "APGE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=APGE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();